Gilead Sciences reports positive data in remdesivir trial for Covid-19

Gilead Sciences said on Wednesday that early results from a US government-run study showed its experimental drug to treat coronavirus helped patients recover more quickly than standard care, suggesting it could become the first effective treatment for an illness that has turned modern life inside-out.
 

The company issued a news release early Wednesday commenting on the study from the US National Institute of Allergy and Infectious Diseases without providing details of the results.
 

Anthony Fauci, the head of NIAID and the government’s top infectious-disease specialist, said at a White House meeting with President Donald Trump and Louisiana Governor John Bel